Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. 1980

S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011867 Radioisotope Teletherapy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. Teleradioisotope Therapy,Teletherapy, Radioisotope,Therapy, Teleradioisotope
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
May 2005, Radiation medicine,
S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
October 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
July 1989, Nihon Gan Chiryo Gakkai shi,
S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
November 1991, Clinical oncology (Royal College of Radiologists (Great Britain)),
S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
February 1986, European journal of cancer & clinical oncology,
S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
October 1981, Cancer,
S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
April 1979, Cancer,
S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
March 2000, Current oncology reports,
S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
July 1988, International journal of radiation oncology, biology, physics,
S Monfardini, and A Banfi, and G Bonadonna, and F Rilke, and F Milani, and P Valagussa, and A Lattuada
January 1997, Acta oncologica (Stockholm, Sweden),
Copied contents to your clipboard!